Select the appropriate incubation period of the Infectious mononucleosis infectious disease of childhood.
A. 16 days
B. 78 days
C. 810 days
D. 1021 days
E. 3050 days
F. 120180 days
Correct Answer: E
The incubation period for diphtheria is 17 days. The incubation period for chicken pox is 1021 days, average 14. Infectious mononucleosis, caused by the Epstein-Barr virus, has an estimated incubation period of 3050 days. The incubation period following infection by the mumps virus is usually 1618 days but, like chicken pox, may vary from 14 to 25 days. Pertussis has a shorter incubation period, usually 710 days, with a variation of 421 days. The usual period from contamination with tetanus spores to clinical symptoms is generally 68 days. For rubella, the incubation period is from 14 to 21 days, but usually ranges from 16 to 18 days.
Question 332:
Select the appropriate incubation period of the Chicken pox infectious disease of childhood.
A. 16 days
B. 78 days
C. 810 days
D. 1021 days
E. 3050 days
F. 120180 days
Correct Answer: D
The incubation period for diphtheria is 17 days. The incubation period for chicken pox is 1021 days, average 14. Infectious mononucleosis, caused by the Epstein-Barr virus, has an estimated incubation period of 3050 days. The incubation period following infection by the mumps virus is usually 1618 days but, like chicken pox, may vary from 14 to 25 days. Pertussis has a shorter incubation period, usually 710 days, with a variation of 421 days. The usual period from contamination with tetanus spores to clinical symptoms is generally 68 days. For rubella, the incubation period is from 14 to 21 days, but usually ranges from 16 to 18 days.
Question 333:
Select the appropriate incubation period of the Diphtheria infectious disease of childhood.
A. 16 days
B. 78 days
C. 810 days
D. 1021 days
E. 3050 days
F. 120180 days
Correct Answer: A
The incubation period for diphtheria is 17 days. The incubation period for chicken pox is 1021 days, average 14. Infectious mononucleosis, caused by the Epstein-Barr virus, has an estimated incubation period of 3050 days. The incubation period following infection by the mumps virus is usually 1618 days but, like chicken pox, may vary from 14 to 25 days. Pertussis has a shorter incubation period, usually 710 days, with a variation of 421 days. The usual period from contamination with tetanus spores to clinical symptoms is generally 68 days. For rubella, the incubation period is from 14 to 21 days, but usually ranges from 16 to 18 days.
Question 334:
From the below clinical indications, choose an option for use of immune globulin (IG) in Rubella prophylaxis
A. indicated
B. not proven effective
C. not routinely indicated
D. contraindicated
E. compulsory
Correct Answer: C
IG given before exposure or within 14 days of exposure is 7585% effective in preventing symptomatic illness from hepatitis A. IG is produced from the plasma of normal adults and does not contain sufficient antibody to prevent hepatitis B infection. Hepatitis B immune globulin (HBIG) is prepared from plasma known to contain high antibody titers for hepatitis B surface antigen (HBsAg) and is specific for hepatitis B. Given immediately postexposure, and again 1 month later, it has a combined efficacy of about 75% in the prevention of hepatitis B. Postexposure IG has not been found effective in the prevention of hepatitis C infection; on the other hand, treatment of early hepatitis C infection is possible, and thus it is important to monitor exposed individuals to determine whether infection occurs. IG administered to individuals exposed to measles infection who are susceptible to the disease has been shown to be effective if given within 6 days of exposure.
Recent use of IG is a contraindication to immunization with rubella vaccine. IG is not very effective at preventing in utero infection with rubella, and infants with congenital rubella syndrome have been born to women given IG shortly after exposure. IG is not routinely indicated, as it is indicated only if abortion is not elected.
Question 335:
From the below the clinical indications, choose an option for use of immune globulin (IG) in Measles prophylaxis
A. indicated
B. not proven effective
C. not routinely indicated
D. contraindicated
E. compulsory
Correct Answer: A
IG given before exposure or within 14 days of exposure is 7585% effective in preventing symptomatic illness from hepatitis A. IG is produced from the plasma of normal adults and does not contain sufficient antibody to prevent hepatitis B infection. Hepatitis B immune globulin (HBIG) is prepared from plasma known to contain high antibody titers for hepatitis B surface antigen (HBsAg) and is specific for hepatitis B. Given immediately postexposure, and again 1 month later, it has a combined efficacy of about 75% in the prevention of hepatitis B. Postexposure IG has not been found effective in the prevention of hepatitis C infection; on the other hand, treatment of early hepatitis C infection is possible, and thus it is important to monitor exposed individuals to determine whether infection occurs. IG administered to individuals exposed to measles infection who are susceptible to the disease has been shown to be effective if given within 6 days of exposure.
Recent use of IG is a contraindication to immunization with rubella vaccine. IG is not very effective at preventing in utero infection with rubella, and infants with congenital rubella syndrome have been born to women given IG shortly after exposure. IG is not routinely indicated, as it is indicated only if abortion is not elected.
Question 336:
From the below the clinical indications, choose an option for use of immune globulin (IG) in Hepatitis C prophylaxis
A. indicated
B. not proven effective
C. not routinely indicated
D. contraindicated
E. compulsory
Correct Answer: B
IG given before exposure or within 14 days of exposure is 7585% effective in preventing symptomatic illness from hepatitis A. IG is produced from the plasma of normal adults and does not contain sufficient antibody to prevent hepatitis B infection. Hepatitis B immune globulin (HBIG) is prepared from plasma known to contain high antibody titers for hepatitis B surface antigen (HBsAg) and is specific for hepatitis B. Given immediately postexposure, and again 1 month later, it has a combined efficacy of about 75% in the prevention of hepatitis B. Postexposure IG has not been found effective in the prevention of hepatitis C infection; on the other hand, treatment of early hepatitis C infection is possible, and thus it is important to monitor exposed individuals to determine whether infection occurs. IG administered to individuals exposed to measles infection who are susceptible to the disease has been shown to be effective if given within 6 days of exposure.
Recent use of IG is a contraindication to immunization with rubella vaccine. IG is not very effective at preventing in utero infection with rubella, and infants with congenital rubella syndrome have been born to women given IG shortly after exposure. IG is not routinely indicated, as it is indicated only if abortion is not elected.
Question 337:
From the below the clinical indications, choose an option for use of immune globulin (IG) in Hepatitis B prophylaxis
A. indicated
B. not proven effective
C. not routinely indicated
D. contraindicated
E. compulsory
Correct Answer: B
IG given before exposure or within 14 days of exposure is 7585% effective in preventing symptomatic illness from hepatitis A. IG is produced from the plasma of normal adults and does not contain sufficient antibody to prevent hepatitis B infection. Hepatitis B immune globulin (HBIG) is prepared from plasma known to contain high antibody titers for hepatitis B surface antigen (HBsAg) and is specific for hepatitis B. Given immediately postexposure, and again 1 month later, it has a combined efficacy of about 75% in the prevention of hepatitis B. Postexposure IG has not been found effective in the prevention of hepatitis C infection; on the other hand, treatment of early hepatitis C infection is possible, and thus it is important to monitor exposed individuals to determine whether infection occurs. IG administered to individuals exposed to measles infection who are susceptible to the disease has been shown to be effective if given within 6 days of exposure.
Recent use of IG is a contraindication to immunization with rubella vaccine. IG is not very effective at preventing in utero infection with rubella, and infants with congenital rubella syndrome have been born to women given IG shortly after exposure. IG is not routinely indicated, as it is indicated only if abortion is not elected.
Question 338:
From the below the clinical indications, choose an option for use of immune globulin (IG) in Hepatitis A prophylaxis
A. indicated
B. not proven effective
C. not routinely indicated
D. contraindicated
E. compulsory
Correct Answer: A
IG given before exposure or within 14 days of exposure is 7585% effective in preventing symptomatic illness from hepatitis A. IG is produced from the plasma of normal adults and does not contain sufficient antibody to prevent hepatitis B infection. Hepatitis B immune globulin (HBIG) is prepared from plasma known to contain high antibody titers for hepatitis B surface antigen (HBsAg) and is specific for hepatitis B. Given immediately postexposure, and again 1 month later, it has a combined efficacy of about 75% in the prevention of hepatitis B. Postexposure IG has not been found effective in the prevention of hepatitis C infection; on the other hand, treatment of early hepatitis C infection is possible, and thus it is important to monitor exposed individuals to determine whether infection occurs. IG administered to individuals exposed to measles infection who are susceptible to the disease has been shown to be effective if given within 6 days of exposure.
Recent use of IG is a contraindication to immunization with rubella vaccine. IG is not very effective at preventing in utero infection with rubella, and infants with congenital rubella syndrome have been born to women given IG shortly after exposure. IG is not routinely indicated, as it is indicated only if abortion is not elected.
Question 339:
For the screening tests listed below, select the screening schedule that is appropriate for women (as per the U.S. Preventive Services Task Force [USPSTF], The Guide to Clinical Preventive Services, 2006) Palpation, ultrasound, or serologic testing of the abdomen to screen for cancer of the pancreas
A. do not routinely screen
B. yearly over age 50
C. at first prenatal visit
D. every 12 years at age 40 and older
E. every 12 years at age 50 and older
F. every 3 years following an initial examination, but not after age 65
G. every 3 years at age 50 and older
Correct Answer: A
The USPSTF recommends against routine screening for pancreatic cancer in asymptomatic adults
Question 340:
For the screening tests listed below, select the screening schedule that is appropriate for women (as per the U.S. Preventive Services Task Force [USPSTF], The Guide to Clinical Preventive Services, 2006)
Screening for hepatitis B
A. do not routinely screen
B. yearly over age 50
C. at first prenatal visit
D. every 12 years at age 40 and older
E. every 12 years at age 50 and older
F. every 3 years following an initial examination, but not after age 65
G. every 3 years at age 50 and older
Correct Answer: C
The USPSTF strongly recommends screening pregnant women for hepatitis B at their first prenatal visit, but recommends against screening the general population.
Nowadays, the certification exams become more and more important and required by more and more enterprises when applying for a job. But how to prepare for the exam effectively? How to prepare for the exam in a short time with less efforts? How to get a ideal result and how to find the most reliable resources? Here on Vcedump.com, you will find all the answers. Vcedump.com provide not only USMLE exam questions, answers and explanations but also complete assistance on your exam preparation and certification application. If you are confused on your USMLE-STEP-2 exam preparations and USMLE certification application, do not hesitate to visit our Vcedump.com to find your solutions here.